Stefanie Sarantopoulos
Chief of Hematologic Malignancies and Cellular Therapy · Duke University School of Medicine
Credentials: · ·
History
PresentHematologic Malignancies and Cellular Therapy Division · Duke University School of Medicine
Research
Biology of Blood and Marrow Transplantation · 2017 · 363 citations
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Blood · 2009 · First of 13 authors · Corresponding · 266 citations
High levels of B-cell activating factor in patients with active chronic graft-versus-host disease
Clinical Cancer Research · 2007 · First of 8 authors · 206 citations
32 papers
29 papers
24 papers
23 papers
22 papers
20 papers
20 papers
19 papers
Grants
- 2015–2031
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
National Heart, Lung, and Blood Institute · R01
Contact PI · $7.7M · Duke University
- 2025–2027
Harnessing B Cells After Stem Cell Transplant to Produce Novel CAR-Ts
National Cancer Institute · R21
Contact PI · $415.3K · Duke University
- 1997–2024
Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $69.9K · Duke University
- 2011–2015
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft Versus Host Disease
National Heart, Lung, and Blood Institute · K08
Contact PI · $520.4K · Duke University
Clinical trials
- 2016–2022
Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant
Principal investigator · Completed · Phase 1
Stefanie Sarantopoulos, MD, PhD.